Your session is about to expire
← Back to Search
Subjects Free of Inflammatory Disease for Rheumatoid Arthritis
Phase 2
Waitlist Available
Research Sponsored by Navidea Biopharmaceuticals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 39 days
Awards & highlights
Study Summary
This study is evaluating whether a drug called tilmanocept can be used to measure the amount of a drug in the blood.
Eligible Conditions
- Rheumatoid Arthritis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 39 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 39 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Normal Limits of TUVjoint in Healthy Subjects
Qualitative Evaluation of SPECT/CT for Tilmanocept Localization
Secondary outcome measures
Normal Distribution of TUVjoint
Planar and SPECT/CT Comparison
Quantitative Evaluation of SPECT/CT
Trial Design
2Treatment groups
Experimental Treatment
Group I: Subjects Free of Inflammatory DiseaseExperimental Treatment1 Intervention
The first arm will be comprised of HCs who are deemed to be clinically free of inflammatory diseases, arthropathies, and/or arthroplasties and clinically free of joint pain for at least 28 days prior to the consent date.
Group II: Healthy Controls and RA Subjects on Stable TherapyExperimental Treatment1 Intervention
The second arm is comprised of [1] disease-free HCs and [2] clinically diagnosed RA subjects on stable treatment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tc99m tilmanocept
2015
Completed Phase 2
~30
Find a Location
Who is running the clinical trial?
Navidea BiopharmaceuticalsLead Sponsor
20 Previous Clinical Trials
1,773 Total Patients Enrolled
4 Trials studying Rheumatoid Arthritis
681 Patients Enrolled for Rheumatoid Arthritis
Michael Blue, MDStudy DirectorNavidea Biopharmaceuticals
9 Previous Clinical Trials
742 Total Patients Enrolled
4 Trials studying Rheumatoid Arthritis
681 Patients Enrolled for Rheumatoid Arthritis
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger